Completed

LASER TREATMENT OF TATTOOS WITH A DUAL WAVELENGTH PICOSECOND LASER

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Picosecond Laser system

Device
Who is being recruted

From 18 to 85 Years
+15 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: October 2013
See protocol details

Summary

Principal SponsorSyneron Medical
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2013

Actual date on which the first participant was enrolled.

The Investigational device is a dual wavelength laser system developed for treatment of pigmented lesions and for tattoo removal. The base unit is a GentleMax Pro laser system modified to emit light at wavelengths of 532 and 1064 nm and deliver pulse energy up to 400mJ, and pulse duration of 700 ps. A multicenter study.

Official TitleLASER TREATMENT OF TATTOOS WITH A DUAL WAVELENGTH PICOSECOND LASER
NCT02146807
Principal SponsorSyneron Medical
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 85 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

4 inclusion criteria required to participate
Has Fitzpatrick skin type I-IV
Has unwanted non-cosmetic tattoo(s) and wishes to undergo laser treatments to remove them
Is willing to consent to participate in the study
Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits
11 exclusion criteria prevent from participating
Is hypersensitive to light exposure
Has an active sun tan
Has Fitzpatrick skin type V or VI
Has active localized or systemic infection
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 3 locations

Suspended

Washington Institute of Dermatologic Laser Surgery

Washington D.C., United StatesOpen Washington Institute of Dermatologic Laser Surgery in Google Maps
Suspended

New York Laser and Skin Care

New York, United States
Suspended

Main Line Center for Laser Surgery

Ardmore, United States
Completed3 Study Centers